Action News reporter Corey Davis put on his science hat to test some interesting experiments that demonstrate the power of ...
Maze Therapeutics, a kidney disease therapy developer, recently IPO-ed with a market cap of $487mn and significant early-stage investor backing. Lead asset MZE829 targets APOL1 Kidney Disease, showing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results